探索过去以启示未来:优化严重烧伤患儿万古霉素的药代动力学
该回顾性分析纳入115例年龄0.2个月至18岁、烧伤面积>10%总体表面积的严重烧伤患儿,采用非线性混合效应模型(Monolix 2016R1版)建立万古霉素群体药代动力学模型。一室模型显示稳态分布容积(V)取决于体重,清除率(CL)受年龄和估算肌酐清除率(CrCL)影响;研究中位V为1.25 L/kg(95%CI 1.04-1.46),中位CL为0.15 L/h/kg(95%CI 0.126-0.165)。
要点
- 严重烧伤患儿万古霉素清除率和分布容积变异大,体重、年龄和估算肌酐清除率为重要协变量。
- 该群体中位分布容积为1.25 L/kg(95%CI 1.04-1.46),中位清除率为0.15 L/h/kg(95%CI 0.126-0.165)。
- 严重烧伤患儿急性肾损伤发生率超过50%,有效给药并避免不必要毒性对改善结局至关重要。
核心结论
- 该分析确定体重、年龄和估算肌酐清除率是预测万古霉素药代动力学的重要协变量,清除率和分布容积变异大。
研究设计与样本
- 回顾性分析纳入115例年龄0.2个月至18岁、烧伤面积>10%总体表面积的严重烧伤患儿。
- 万古霉素经静脉输注给药,输注后6至12小时采血。
- 采用非线性混合效应模型(Monolix 2016R1版)建立群体药代动力学模型。
主要发现
- 一室模型描述稳态分布容积,其取决于体重;万古霉素清除率受年龄和估算肌酐清除率影响。
- 研究人群中位年龄4岁、中位体重20 kg、中位总体表面积百分比40%。
- 研究人群中位分布容积为1.25 L/kg(95%CI 1.04-1.46),中位清除率为0.15 L/h/kg(95%CI 0.126-0.165)。
关键数值与推荐
- 严重烧伤患儿急性肾损伤发生率超过50%。
- 万古霉素中位分布容积1.25 L/kg(95%CI 1.04-1.46),中位清除率0.15 L/h/kg(95%CI 0.126-0.165)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 该药代动力学模型系明确利用有限数据建立,以表征18岁以下儿童生理变化及烧伤表面积百分比的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sepsis remains one of the leading causes of death among pediatric patients with burn injuries. Despite limited vancomycin pharmacokinetic (PK) information within this population, it is widely used to treat severe burn injuries. Those with severe burns are at risk of nephrotoxicity, with an incidence of acute kidney injury (AKI) over 50%. Delivering an effective vancomycin dose and avoiding unnecessary toxicity is essential for improved patient outcomes. This was a retrospective analysis of 115 children aged 0.2 months to 18 years with severe burns, >10% total body surface area. Vancomycin was given via intravenous infusion; blood samples were drawn between 6- and 12-hour postinfusion. A population pharmacokinetic model was developed using nonlinear mixed-effect modeling (Monolix, version 2016R1). A one-compartment model described a steady-state volume of distribution (V), dependent on weight. Vancomycin clearance (CL) was influenced by age and estimated creatinine clearance (CrCL). The study population's (median age = 4 years, median weight = 20 kg, median total body surface area (%TBSA) = 40%) median V and CL were calculated to be 1.25 L/kg (95% CI, 1.04-1.46) and 0.15 L/h/kg (95% CI, 0.126-0.165), respectively. The PK model was explicitly developed to characterize the impact of physiological changes in children under 18 years of age and the percentage of the burn surface area using limited data. The analysis determined that weight, age, and estimated CrCL were important covariates in predicting vancomycin PK with high variability in CL and V.
引用
- Sherwin CM, Tran NK, Sullivan K, et al. Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries. J Burn Care Res. 2023. PMID: 36194537. doi:10.1093/jbcr/irac147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。